Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
293
-
Total 13F shares, excl. options
-
49.7M
-
Shares change
-
-1.22M
-
Total reported value, excl. options
-
$1.98B
-
Value change
-
-$48.8M
-
Put/Call ratio
-
1.88
-
Number of buys
-
133
-
Number of sells
-
-132
-
Price
-
$39.85
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2017
331 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2017.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 293 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.7M shares
of 56M outstanding shares and own 88.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.9M shares), Vanguard Group Inc (4.58M shares), Invesco Ltd. (1.59M shares), STATE STREET CORP (1.53M shares), Bank of New York Mellon Corp (1.43M shares), DIMENSIONAL FUND ADVISORS LP (1.4M shares), RICE HALL JAMES & ASSOCIATES, LLC (1.32M shares), ACADIAN ASSET MANAGEMENT LLC (1.28M shares), Champlain Investment Partners, LLC (1.21M shares), and ROTHSCHILD ASSET MANAGEMENT INC (1.09M shares).
This table shows the top 293 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.